Navigation Links
Production of Hybridomas by Electrofusion
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Production Hybridomas Electrofusion

(Date:4/1/2015)... 1, 2015 Synthetic Biologics, Inc. (NYSE ... serious infections and diseases, with a focus on ... supporting the development of SYN-004, the Company,s candidate ... antibiotics within the gastrointestinal (GI) tract and maintain ... the prevention of C. difficile infection, ...
(Date:4/1/2015)... CA (PRWEB) April 01, 2015 The concept ... loss, a multi-billion dollar industry. Founder of Fasciology, Ashley Black, ... an area of fat, instead of having to wait for ... Black claims that “ prior to fat cooling procedures, ... sculpting or contouring, was liposuction, which is a highly invasive ...
(Date:3/31/2015)... CytoSorbents Corporation (NASDAQ CM: CTSO), a ... treat critically-ill and cardiac surgery patients in multiple ... financial results for the fiscal year ending December ... revenues were a record $3.1M, an increase of ... of $0.8M Highlights for the Year Ending December ...
(Date:3/31/2015)... , March 31, 2015 Materials ... ,   June 30 2015   ... information products and services and publishing home of Materials ... has launched the Materials in Society  Lecture Series ... the 8 th International Conference on Materials for ...
Breaking Biology Technology:Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 2Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 3Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 4Hybrid Health Guru, Ashley Black, announces that her invention The FasciaBlaster™ rivals the “fat cooling” procedures that reduce exercise and diet resistant fat pockets. 2Hybrid Health Guru, Ashley Black, announces that her invention The FasciaBlaster™ rivals the “fat cooling” procedures that reduce exercise and diet resistant fat pockets. 3CytoSorbents Reports Record 2014 Revenue 2CytoSorbents Reports Record 2014 Revenue 3CytoSorbents Reports Record 2014 Revenue 4CytoSorbents Reports Record 2014 Revenue 5CytoSorbents Reports Record 2014 Revenue 6CytoSorbents Reports Record 2014 Revenue 7CytoSorbents Reports Record 2014 Revenue 8CytoSorbents Reports Record 2014 Revenue 9CytoSorbents Reports Record 2014 Revenue 10CytoSorbents Reports Record 2014 Revenue 11Elsevier Materials Science Council Introduces the Materials in Society Lecture Series at the International Conference on Materials for Advanced Technologies (ICMAT) 2Elsevier Materials Science Council Introduces the Materials in Society Lecture Series at the International Conference on Materials for Advanced Technologies (ICMAT) 3
... state,s presence is a prelude to the 2009 convention to be held in ... ... showcase its bioscience,leadership at the 2008 Bio international convention on June 17 -- ... meet,with state and business leaders during the convention., "As one of the ...
... Million; Access Gains Second Source ... Trial Support, DALLAS and NANJING, PRC, June 4 ... Aosaikang,Pharmaceutical Co., LTD. ("ASK"), a premier pharmaceutical company focused,on ... the,signing of a definitive licensing agreement under which ASK ...
... June 4 In response to numerous,shareholder questions, ... an,update on the construction of its manufacturing facility ... will comprise 73,000 square,feet and will be used ... dedicated facility will produce the Multikine that,will be ...
Cached Biology Technology:Georgia Showcases its Bioscience Leadership at 2008 Bio International Convention 2Georgia Showcases its Bioscience Leadership at 2008 Bio International Convention 3Access Licenses ProLindac(TM) to Jiangsu Aosaikang Pharmaceutical Co., LTD., a Leading Oncology Pharmaceutical Company for Manufacturing, Development and Commercialization in the Greater China Region 2Access Licenses ProLindac(TM) to Jiangsu Aosaikang Pharmaceutical Co., LTD., a Leading Oncology Pharmaceutical Company for Manufacturing, Development and Commercialization in the Greater China Region 3CEL-SCI CORPORATION Manufacturing Facility for Pivotal Phase III Cancer Trial Scheduled to Be Completed During 2008 Third Quarter 2CEL-SCI CORPORATION Manufacturing Facility for Pivotal Phase III Cancer Trial Scheduled to Be Completed During 2008 Third Quarter 3
(Date:3/16/2015)... Germany , March 16, 2015 ... Identification Systems GmbH will present groundbreaking innovations in ... Hanover, Germany .      ... DERMALOG,s latest biometric innovation is well at the ... next generation e-gate made in Germany ...
(Date:3/11/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/3p32qm/access_control ) has ... by Product, Application & By Geography - Global Forecast ... , This report predicts that the access ... 2020, with an estimated CAGR of 10.6%. ... such as contact cards & readers, contactless cards & ...
(Date:3/10/2015)... Conn. , March 10, 2015  NXT-ID, ... ("NXT-ID" or the "Company"), a biometric authentication company ... the company,s Wocket™ smart wallet has been named ... by Rethink Modern. Rethink Modern ( ... and innovative items for your home and lifestyle that have ...
Breaking Biology News(10 mins):DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 4
... Rutgers researchers have discovered a potential new way ... drug. Rutgers neuroscientist Gabriella D,Arcangelo and her colleagues ... Disease Models and Mechanisms (in press) and the ... for new therapeutic approaches, the researchers are investigating the ...
... This release is available in German . ... particularly true for cancer medicine. The chances of cure ... research results are swiftly transferred from the laboratory into ... called translational research, will now be optimized in Germany. ...
... By mid-century, people may be fleeing rising ... migrations that could vastly exceed the scope of anything before, ... at Columbia University,s Center for International Earth Science Information Network ... today at a news conference in Bonn. , ...
Cached Biology News:Rutgers research tackles childhood epilepsy 2German Research Minister Schavan: 'Rapid knowledge transfer can safe lives' 2German Research Minister Schavan: 'Rapid knowledge transfer can safe lives' 3Climate change could drive vast human migrations 2Climate change could drive vast human migrations 3
... dye terminators, template DNA, primers, salts or ... products have proved critical for both standard ... to work with dye terminator cycle sequencing ... The unique uniformity of the magnetic paeticles ...
Enodgenous alkaline phosphotase inhibitor. Levamisole solution is supplied in concentrated form (20x). The final concentration of levamisole in the substrate solution will be 1 mM....
uncoupling protein 2 (mitochondrial, proton carrier), mRNA (cDNA clone MGC:19567 IMAGE:4335185), complete cds...
Catch and Release® v2.0 Reversible Immunoprecipitation System...
Biology Products: